(Q46489865)

22 December 2017

title

Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke (English)

1 reference

22 December 2017

1 reference

1 reference

1 reference

1 reference

Edelgard Lindhoff-Last

6

object named as

Edelgard Lindhoff-Last

0 references

Michel Mittelbronn

4

object named as

Michel Mittelbronn

1 reference

22 December 2017

Waltraud Pfeilschifter

1

1 reference

22 December 2017

Ferdinand Bohmann

2

1 reference

22 December 2017

Peter Baumgarten

3

1 reference

22 December 2017

Josef Pfeilschifter

5

1 reference

22 December 2017

Edelgard Lindhoff-Last

6

1 reference

22 December 2017

Helmuth Steinmetz

7

1 reference

22 December 2017

Christian Foerch

8

1 reference

22 December 2017

publication date

23 March 2012

1 reference

22 December 2017

published in

Annals of Neurology

1 reference

22 December 2017

volume

71

1 reference

22 December 2017

issue

5

1 reference

22 December 2017

page(s)

624-633

1 reference

22 December 2017

Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor

cites work

1 reference

Dabigatran versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

Guidelines for the Early Management of Adults With Ischemic Stroke

21 January 2018

1 reference

Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran

21 January 2018

1 reference

Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran.

21 January 2018

1 reference

Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage

21 January 2018

1 reference

Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity

21 January 2018

1 reference

Experimental model of warfarin-associated intracerebral hemorrhage

21 January 2018

1 reference

Rapid reversal of anticoagulation reduces hemorrhage volume in a mouse model of warfarin-associated intracerebral hemorrhage

21 January 2018

1 reference

Increased risk of hemorrhagic transformation in ischemic stroke occurring during warfarin anticoagulation: an experimental study in mice

21 January 2018

1 reference

Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats.

21 January 2018

1 reference

Rapid reversal of anticoagulation prevents excessive secondary hemorrhage after thrombolysis in a thromboembolic model in rats

21 January 2018

1 reference

Warfarin anticoagulation exacerbates the risk of hemorrhagic transformation after rt-PA treatment in experimental stroke: therapeutic potential of PCC

21 January 2018

1 reference

Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study).

21 January 2018

1 reference

Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke

21 January 2018

1 reference

Direct thrombin inhibitors

21 January 2018

1 reference

Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor

21 January 2018

1 reference

Hemostatic therapy in experimental intracerebral hemorrhage associated with the direct thrombin inhibitor dabigatran.

21 January 2018

1 reference

Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial

21 January 2018

1 reference

Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects

21 January 2018

1 reference

Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.23558

1 reference

22 December 2017

PubMed ID

22447744

1 reference

22 December 2017